From the battlefield to the factory, Palantir is going on an AI offensive
We mined Palantir's investments and partnerships since Q1’23 to discern the company's strategic priorities.
We mined Palantir's investments and partnerships since Q1’23 to discern the company's strategic priorities.
We dive into the data on leading companies attending the conference, including headcount growth, key partnerships, and recent funding rounds.
We break down the rise of India’s AI sector across headcount growth, big tech investment, and VC deal activity.
We dive into the data on leading companies attending the conference, including headcount growth, key partnerships, and recent funding rounds.
From deal activity to top investors, we analyze the shifting landscape for AI in clinical trials to determine how the tech is transforming drug development for the better.
Using CB Insights data, we highlight 6 predictions that pose disruption risks for insurance giants and emerging players.
From clinical operations to drug development, we mapped 85+ startups bringing generative AI to the healthcare and life sciences industries.
From increasing specialization to rising infrastructure markets, here’s where the opportunities lie across the AI agent landscape.
From data loss prevention to IoT security, we map 135+ companies helping healthcare organizations combat cyber threats.
Gaming investment rallied in 2024. Here’s how emerging tech is making gaming more immersive, responsive, and secure.
From autonomous yard vehicles to warehouse AI copilots, we map 275+ companies modernizing warehouse operations and explore 3 trends driving automation forward.
As performance gaps narrow and model costs drop, the open vs. closed model debate is in the spotlight. This brief explores enterprise adoption in the landscape and the cost dynamics reshaping the divide.
We highlight notable generative AI deals, partnerships, and notable releases in January 2025.
We dig into the implications of China-based DeepSeek’s rapid ascent on the AI infrastructure landscape, the private sector, and enterprise AI strategies.
Tech companies' growing power demands and component supply shortages have altered nuclear development timelines. We look at how fusion startups and small modular reactor (SMR) developers are adapting.
Critical infrastructure sectors are being exposed to costly cyberattacks. This brief explores how industrials firms have responded by investing in and partnering with OT security firms and how healthcare companies can follow suit.
We highlight notable generative AI deals, partnerships, and big tech activity in December 2024.
AI promises to accelerate the path from bench to bedside. Using CB Insights data, we highlight emerging markets in the preclinical phase that are ripe for pharma investments and partnerships.
We map out 60+ companies developing AI agents & copilots for industrial applications, including manufacturing, logistics, semiconductors, defense, and construction.
We analyze funding and acquisitions data, clinical progress, and partnership strategies to help pharma companies and investors navigate the maturing AI landscape in drug discovery.
Pharma giants and diagnostic testing leaders looking to expand in cancer detection should watch high-momentum liquid biopsy startups like Harbinger Health and Delfi Diagnostics.
From screening resumes to conducting assessments and handling questions, we map the new wave of companies automating employee hiring and break down what HR leaders need to know about the market.
We highlight notable generative AI deals, partnerships, and big tech activity in November 2024.
With the rise of EVs and AVs, fleet management solutions are expanding in scope to accommodate blended fleets. We break down what this means for fleet telematics & management companies, identifying who they should have on their radars to build out their capabilities.
We mined Roche’s acquisitions, investments, and partnerships to discern the company's strategic priorities. Here’s what pharma and diagnostics companies need to pay attention to.
From in-home humanoids to autonomous labs, we highlight the growing opportunities in robotics markets for providers and other healthcare stakeholders.